Scilex Holding Co
SCLXNasdaqCIK 1820190HealthcareFiscal year ends Dec 31
Reports and events: 215 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2025-05-1208:52 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-068621 |
| 2025-04-3016:31 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-061130 |
| 2025-04-2917:00 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0000950170-25-060302 |
| 2025-04-2210:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-056497 |
| 2025-04-2108:59 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-25-056022 |
| 2025-04-1509:00 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-25-080856 |
| 2025-04-1109:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-078604 |
| 2025-03-3116:30 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-047800 |
| 2025-03-2016:29 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-042708 |
| 2025-03-1009:09 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-035963 |
| 2025-03-0313:55 ET | 8-K | 1.02 Termination of a material agreement | 0001193125-25-043879 |
| 2025-03-0306:15 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-043338 |
| 2025-02-2716:07 ET | DEF 14A | Proxy statementPeriod 2025-03-19 | 0001193125-25-039223 |
| 2025-02-2716:05 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-039211 |
| 2025-01-2321:21 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000950170-25-008501 |
| 2025-01-2206:04 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-009911 |
| 2025-01-2116:58 ET | 8-K | 8.01 Other events | 0000950170-25-007359 |
| 2025-01-1716:34 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-25-006755 |
| 2025-01-0619:11 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000950170-25-002435 |
| 2025-01-0306:06 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-000984 |
| 2024-12-3009:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-286244 |
| 2024-12-1313:50 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-278311 |
| 2024-12-1008:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-134767 |
| 2024-12-1006:05 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-273896 |
| 2024-12-0609:18 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0000950170-24-133869 |
| 2024-11-2917:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-268137 |
| 2024-11-2215:11 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-264187 |
| 2024-11-2206:16 ET | 8-K | 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-263748 |
| 2024-11-2206:04 ET | 8-K/A | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001193125-24-263737 |
| 2024-11-2006:04 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001193125-24-262065 |
| 2024-11-0716:30 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001193125-24-253177 |
| 2024-11-0612:44 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-251872 |
| 2024-10-2806:27 ET | 8-K | 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-117557 |
| 2024-10-0817:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-113581 |
| 2024-10-0812:56 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-234244 |
| 2024-10-0717:24 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-233897 |
| 2024-09-2309:03 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-24-108658 |
| 2024-09-1809:01 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-107615 |
| 2024-09-0916:11 ET | SC 13D | Ownership report, active investor | 0001193125-24-215901 |
| 2024-09-0309:06 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-211651 |
| 2024-08-1316:10 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-096199 |
| 2024-08-0109:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-088984 |
| 2024-07-2517:19 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-086629 |
| 2024-07-0813:53 ET | 8-K | 7.01 Regulation FD disclosure | 0000950170-24-082027 |
| 2024-07-0217:23 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-080768 |
| 2024-07-0109:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-079287 |
| 2024-06-2809:00 ET | 8-K | 7.01 Regulation FD disclosure | 0000950170-24-078800 |
| 2024-06-2106:05 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-24-165059 |
| 2024-06-1715:33 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-24-162568 |
| 2024-06-1216:01 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-24-159926 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.